Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Medical services are provided by an independently-owned physician practice
Results become inconsistent
declares research contracts with Daiichi Sankyo, Eleor, Kaleido Biosciences, Lytix Pharma, PharmaMar, Osasuna Therapeutics, Samsara Therapeutics, Sanofi, Sutro Biopharma, Tollys, and VASCage
Consistency matters more than intensity
One double-blind, placebo-controlled RCT by investigated the use of ALC for the treatment of established CIPN (grade 2 or 3, NCI-CTC v3.0) in 240 patients with various solid tumours
US$ 23.15
US$ 27.34
US$ 27.70
US$ 23.42
